Interestingly, genome-wide hypomethylation has been reported in CAD [80], and has also been seen in homocysteine-treated VSMCs, despite increased levels of DNMT3A and DNMT3B [81]. This evidence concerns the gene DNMT3A and coronary artery disorder.